← Back to Search

Unknown

S-309309 for Obesity

Phase 1
Waitlist Available
Research Sponsored by Shionogi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 2, 3, 4, 5, 6, 7 and 16
Awards & highlights

Study Summary

This trial is testing a new drug to see if it is safe and tolerated in healthy adults, as well as its effects on the heart.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 2, 3, 4, 5, 6, 7 and 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 2, 3, 4, 5, 6, 7 and 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Part 1 and 2: Number of Participants with Treatment Emergent Adverse Events (TEAEs)
Secondary outcome measures
Part 1: Apparent Total Clearance (CL/F) of S-309309
Part 1: Apparent Volume of Distribution (Vz/F) of S-309309
Part 1: Area Under the Plasma Concentration-Time Curve (AUC) of S-309309
+22 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Part 2: S-309309 and MidazolamExperimental Treatment2 Interventions
Participants will receive S-309309 and Midazolam at specific timepoints fed state.
Group II: Part 1: S-309309Experimental Treatment1 Intervention
Participants will receive S-309309 at specific timepoints in a fasted state.
Group III: Part 1 and 2: PlaceboPlacebo Group1 Intervention
Participants will receive a matching placebo to S-309309 at specific timepoints in either a fed or fasted state.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Midazolam
FDA approved
S-309309
2022
Completed Phase 1
~80

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

ShionogiLead Sponsor
116 Previous Clinical Trials
41,412 Total Patients Enrolled
6 Trials studying Obesity
3,197 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study to Assess S-309309 in Healthy and Obese Participants
2022. "A Study to Assess S-309309 in Healthy and Obese Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05247970.
~22 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top